Read + Share
Surve A, Potts J, Cottam D, Roslin M, et al. The Safety and Efficacy of Apixaban (Eliquis) in 5017 Post-bariatric Patients
with 95.3% Follow-up: a Multicenter Study. Obes Surg 2022;32:1-6.
PMID: 35478402
|
 |
|
Surve A, Potts J, Cottam D, Roslin M, et al. The Safety and Efficacy of Apixaban (Eliquis) in 5017 Post-bariatric Patients
with 95.3% Follow-up: a Multicenter Study. Obes Surg 2022;32:1-6.
PMID: 35478402
|
|
|
|